First-line Therapy of untreated advanced or metastatic Renal Cell Cancer
   Randomized, open, Phase-3 Study of Nivolumab in Combination with
   Cabozantinib versus Sunitinib in Participants with previously untreated,
   advanced or metastatic Renal Cell Cancer

Titel:: First-line Therapy of untreated advanced or metastatic Renal Cell Cancer Randomized, open, Phase-3 Study of Nivolumab in Combination with Cabozantinib versus Sunitinib in Participants with previously untreated, advanced or metastatic Renal Cell Cancer
Dokumenttyp:: Editorial Material
Autor(en):: Rexer, H.; Steiner, T.; Retz, M.
Zeitschriftentitel:: Urologe A
Jahr:: 2018
Band / Volume:: 57
Heft / Issue:: 12
Seitenangaben Beitrag:: 1532-1533
Volltext / DOI:: doi:10.1007/s00120-018-0816-y
Print-ISSN:: 0340-2592
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: